Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Pre-B cell leukemia homeobox 1 is associated with lupus susceptibility in mice and humans.
Cuda CM, Li S, Liang S, Yin Y, Potula HH, Xu Z, Sengupta M, Chen Y, Butfiloski E, Baker H, Chang LJ, Dozmorov I, Sobel ES, Morel L.
J Immunol. 2012 Jan 15;188(2):604-14. Epub 2011 Dec 16.
Related citations
EphB receptors trigger Akt activation and suppress Fas receptor-induced apoptosis in malignant T lymphocytes.
Maddigan A, Truitt L, Arsenault R, Freywald T, Allonby O, Dean J, Narendran A, Xiang J, Weng A, Napper S, Freywald A.
J Immunol. 2011 Dec 1;187(11):5983-94. Epub 2011 Oct 28.
c-Myb and GATA-3 cooperatively regulate IL-13 expression via conserved GATA-3 response element and recruit mixed lineage leukemia (MLL) for histone modification of the IL-13 locus.
Kozuka T, Sugita M, Shetzline S, Gewirtz AM, Nakata Y.
J Immunol. 2011 Dec 1;187(11):5974-82. Epub 2011 Oct 28.
Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication.
Zelinskyy G, Myers L, Dietze KK, Gibbert K, Roggendorf M, Liu J, Lu M, Kraft AR, Teichgräber V, Hasenkrug KJ, Dittmer U.
J Immunol. 2011 Oct 1;187(7):3730-7. Epub 2011 Aug 26.
Loss of CD20 and bound CD20 antibody from opsonized B cells occurs more rapidly because of trogocytosis mediated by Fc receptor-expressing effector cells than direct internalization by the B cells.
Beum PV, Peek EM, Lindorfer MA, Beurskens FJ, Engelberts PJ, Parren PW, van de Winkel JG, Taylor RP.
J Immunol. 2011 Sep 15;187(6):3438-47. Epub 2011 Aug 12.
TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation.
Vire B, David A, Wiestner A.
J Immunol. 2011 Oct 15;187(8):4040-50. Epub 2011 Sep 9.
Intestinal epithelial cells modulate CD4 T cell responses via the thymus leukemia antigen.
Olivares-Villagómez D, Algood HM, Singh K, Parekh VV, Ryan KE, Piazuelo MB, Wilson KT, Van Kaer L.
J Immunol. 2011 Oct 15;187(8):4051-60. Epub 2011 Sep 7.
Graft-versus-leukemia (GVL) against mouse blast-crisis chronic myelogenous leukemia (BC-CML) and chronic-phase chronic myelogenous leukemia (CP-CML): shared mechanisms of T cell killing, but programmed death ligands render CP-CML and not BC-CML GVL resistant.
Matte-Martone C, Venkatesan S, Tan HS, Athanasiadis I, Chang J, Pavisic J, Shlomchik WD.
J Immunol. 2011 Aug 15;187(4):1653-63. Epub 2011 Jul 18.
Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
Kuo CW, Mirsaliotis A, Brighty DW.
J Immunol. 2011 Jul 1;187(1):361-71. Epub 2011 Jun 6.
A naive-like population of human CD1d-restricted T cells expressing intermediate levels of promyelocytic leukemia zinc finger.
Constantinides MG, Picard D, Savage AK, Bendelac A.
J Immunol. 2011 Jul 1;187(1):309-15. Epub 2011 Jun 1.
Analyses of recombinant stereotypic IGHV3-21-encoded antibodies expressed in chronic lymphocytic leukemia.
Ghia EM, Widhopf GF 2nd, Rassenti LZ, Kipps TJ.
J Immunol. 2011 Jun 1;186(11):6338-44. Epub 2011 Apr 27.
Promyelocytic leukemia zinc finger turns on the effector T cell program without requirement for agonist TCR signaling.
Savage AK, Constantinides MG, Bendelac A.
J Immunol. 2011 May 15;186(10):5801-6. Epub 2011 Apr 8.
CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.
Garaud S, Morva A, Lemoine S, Hillion S, Bordron A, Pers JO, Berthou C, Mageed RA, Renaudineau Y, Youinou P.
J Immunol. 2011 Apr 15;186(8):4835-44. Epub 2011 Mar 11.
Requirements for eomesodermin and promyelocytic leukemia zinc finger in the development of innate-like CD8+ T cells.
Gordon SM, Carty SA, Kim JS, Zou T, Smith-Garvin J, Alonzo ES, Haimm E, Sant'Angelo DB, Koretzky GA, Reiner SL, Jordan MS.
J Immunol. 2011 Apr 15;186(8):4573-8. Epub 2011 Mar 7.
TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms.
Verma B, Jain R, Caseltine S, Rennels A, Bhattacharya R, Markiewski MM, Rawat A, Neethling F, Bickel U, Weidanz JA.
J Immunol. 2011 Mar 1;186(5):3265-76. Epub 2011 Jan 31.
Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4- subset dynamics and correlates with remission state.
de Lalla C, Rinaldi A, Montagna D, Azzimonti L, Bernardo ME, Sangalli LM, Paganoni AM, Maccario R, Di Cesare-Merlone A, Zecca M, Locatelli F, Dellabona P, Casorati G.
J Immunol. 2011 Apr 1;186(7):4490-9. Epub 2011 Feb 25.
TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells.
Zhang Y, Luo F, Cai Y, Liu N, Wang L, Xu D, Chu Y.
J Immunol. 2011 Feb 15;186(4):1963-9. Epub 2011 Jan 7.
Anti-NeuGcGM3 antibodies, actively elicited by idiotypic vaccination in nonsmall cell lung cancer patients, induce tumor cell death by an oncosis-like mechanism.
Hernández AM, Rodríguez N, González JE, Reyes E, Rondón T, Griñán T, Macías A, Alfonso S, Vázquez AM, Pérez R.
J Immunol. 2011 Mar 15;186(6):3735-44. Epub 2011 Feb 7.
Mechanism of action of type II, glycoengineered, anti-CD20 monoclonal antibody GA101 in B-chronic lymphocytic leukemia whole blood assays in comparison with rituximab and alemtuzumab.
Bologna L, Gotti E, Manganini M, Rambaldi A, Intermesoli T, Introna M, Golay J.
J Immunol. 2011 Mar 15;186(6):3762-9. Epub 2011 Feb 4.
CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination.
Vicetti Miguel RD, Cherpes TL, Watson LJ, McKenna KC.
J Immunol. 2010 Dec 1;185(11):6706-18. Epub 2010 Nov 1.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on